Sabiia Seb
PortuguêsEspañolEnglish
Embrapa
        Busca avançada

Botão Atualizar


Botão Atualizar

Registro completo
Provedor de dados:  OAK
País:  Japan
Título:  Dextran sulfate inhibits acute Toxoplama gondii infection in pigs
Autores:  Kato, Kentaro
Murata, Yuho
Horiuchi, Noriyuki
Inomata, Atsuko
Terkawi, Mohamad Alaa
Ishiwa, Akiko
Ogawa, Yohsuke
Fukumoto, Shinya
Matsuhisa, Fumikazu
Koyama, Kenji
Data:  2016-03-09
Ano:  2016
Palavras-chave:  Dextran sulfate
Intermediate host
Pig
Public health
Toxoplasma gondii
Resumo:  Background: Toxoplasma gondii is a highly prevalent protozoan that can infect all warm-blooded animals, including humans. Its definitive hosts are Felidae and its intermediate hosts include various other mammals and birds, including pigs. It is found in the meat of livestock which is a major source of human infection. Hence the control of toxoplasmosis in pigs is important for public health. We previously showed that dextran sulfate (DS), especially DS10 (dextran sulfate MW 10 kDa), is effective against T. gondii infection both in vitro and in mice. In this study, we asked whether DS affects T. gondii infection of pigs, one of the main animal sources of toxoplasmosis transmission to humans. Methods: Fourteen-day-old male pigs (n = 10) were infected with T. gondii and then immediately treated with different doses of DS10; clinical, pathological, and immunological analyses were performed 5 days post-infection. Results: DS10 had an inhibitory effect on toxoplasmosis in pigs. Intravenous injection of DS10 prevented the symptoms of toxoplasmosis and reduced the parasite burden and inflammation induced by T. gondii infection. High-dose DS10 (500 mu g per head) caused reversible hepatocellular degeneration of the liver; middle-dose DS10 (50 mu g per head) was effective against toxoplasmosis in pigs without causing this side effect. Conclusions: Our data suggest that middle-dose DS10 led to minimal clinical symptoms of T. gondii infection and caused little hepatocellular degeneration in our pig model, thereby demonstrating its potential as a new treatment for toxoplasmosis. These data should be very beneficial to those interested in the control of toxoplasmosis in pigs.
Idioma:  Inglês
Identificador:  http://ir.obihiro.ac.jp/dspace/handle/10322/4446

info:doi/10.1186/s13071-016-1421-9
Editor:  Biomed Central
Direitos:  This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).
Fechar
 

Empresa Brasileira de Pesquisa Agropecuária - Embrapa
Todos os direitos reservados, conforme Lei n° 9.610
Política de Privacidade
Área restrita

Embrapa
Parque Estação Biológica - PqEB s/n°
Brasília, DF - Brasil - CEP 70770-901
Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco

Valid HTML 4.01 Transitional